SOUTHERN ILLINOIS UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1869-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://siu.edu/index.php
Clinical Trials
33
Active:1
Completed:19
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:7
Phase 2:7
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (28.0%)Phase 2
7 (28.0%)Early Phase 1
3 (12.0%)Not Applicable
3 (12.0%)Phase 4
3 (12.0%)Phase 3
2 (8.0%)Oral Iron Supplementation on Alternate Vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
Phase 4
Recruiting
- Conditions
- PregnancyIron-deficiency Anemia (IDA)
- Interventions
- Drug: daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pillDrug: alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Southern Illinois University
- Target Recruit Count
- 120
- Registration Number
- NCT06492512
- Locations
- 🇺🇸
Southern Illinois University School of Medicine, Springfield, Illinois, United States
Rural Illinois Lung Cancer Screening Initiative
Not yet recruiting
- Conditions
- Lung Cancer
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Southern Illinois University
- Target Recruit Count
- 10000
- Registration Number
- NCT06084078
Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients
Phase 3
Completed
- Conditions
- Non Small Cell Lung CancerLung Cancer Stage 1
- Interventions
- Drug: Bupivacaine-Epinephrine
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Southern Illinois University
- Target Recruit Count
- 57
- Registration Number
- NCT03682224
- Locations
- 🇺🇸
Memorial Medical Center, Southern Illinois University-School of Medicine, Springfield, Illinois, United States
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Southern Illinois University
- Target Recruit Count
- 351
- Registration Number
- NCT02903355
- Locations
- 🇺🇸
Moncrief Army Community Hospital, Fort Jackson, South Carolina, United States
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
Completed
- Conditions
- MRSA
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- Southern Illinois University
- Target Recruit Count
- 33
- Registration Number
- NCT02690415
- Locations
- 🇺🇸
SIU School of Medicine, Springfield, Illinois, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found